10-01-2026 09:39 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Share Holdings
Mankind Pharma Ltd.
 
BSE Code 543904
ISIN Demat INE634S01028
Book Value 375.73
NSE Code MANKIND
Dividend Yield % 0.00
Market Cap 908067.96
P/E 54.36
EPS 40.47
Face Value 1  
Description ( As On September 2025 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  13  299960612  72.67  299960612  
  Foreign Promoter          
  Total Promoter  13  299960612  72.67  299960612  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  32  32127024  7.78  32127024  
  FI/Bank/Insurance  12  7325358  1.77    
  Govt          
  FII          
  Other  581  62575034  15.17  62575034  
  Total Institutions  625  102027416  24.72  102027416  
 Non-Institution          
  Bodies Corporate  623  4409827  1.07  4409827  
  Individuals          
  NRIs/OCBs  2585  227213  0.06  227213  
  Others  166501  6133422  1.48  6133422  
  Total Non-Institution  169709  10770462  2.61  10770462  
Total Non Promoter  170334  112797878  27.33  112797878  
          
  Depository Receipts          
          
Grand Total  170347  412758490  100  412758490  
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.